Central Areolar Choroidal Dystrophy (CACD)

Central Areolar Choroidal Dystrophy (CACD) is a rare inherited macular disease that gradually damages the central part of the retina responsible for detailed vision. As the condition progresses, the retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris in the macula slowly deteriorate, leading to progressive central vision loss while peripheral vision usually remains preserved. CACD most commonly develops during adulthood and progresses over several years.

Although there is currently no cure that can reverse the genetic damage, early diagnosis, regular retinal monitoring, genetic counseling, and low-vision rehabilitation can help patients maintain independence and quality of life.

What is Central Areolar Choroidal Dystrophy?

Central Areolar Choroidal Dystrophy is a hereditary retinal disorder affecting the macula—the area responsible for reading, facial recognition, driving, and other detailed visual tasks.

Unlike age-related macular degeneration (AMD), CACD is primarily caused by inherited genetic mutations rather than aging alone. The disease gradually creates a well-defined area of atrophy in the central retina, causing worsening central vision over time while sparing side vision in most patients.

Symptoms of CACD

Symptoms usually develop gradually and may affect both eyes.

Common symptoms include:

Blurred central vision
Difficulty reading small print
Distorted vision (metamorphopsia)
Reduced color perception
Difficulty recognizing faces
Central blind spot (central scotoma)
Increased sensitivity to bright light
Progressive loss of visual sharpness

Peripheral (side) vision generally remains normal until the advanced stages.

Causes of Central Areolar Choroidal Dystrophy

CACD is primarily a genetic disorder.

The most common cause is mutations in the PRPH2 (Peripherin-2) gene, although other genetic variants have also been identified. The condition is most frequently inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the condition if one parent carries the affected gene. Rare autosomal recessive and sporadic cases have also been reported.

Risk factors include:

Family history of retinal dystrophy
Inherited genetic mutations
Adult age of onset (commonly between 30–60 years)

Stages of CACD

Eye specialists generally classify CACD into four stages:

Stage 1

Mild pigment changes around the macula
Vision often remains normal

Stage 2

Small areas of retinal atrophy begin to appear
Mild visual symptoms develop

Stage 3

Enlargement of atrophic areas
Noticeable reduction in central vision

Stage 4

Complete involvement of the fovea
Significant central vision loss
Peripheral vision usually remains intact

How is CACD Diagnosed?

An experienced retina specialist may recommend several investigations to confirm the diagnosis.

Common diagnostic tests include:

Comprehensive eye examination
Dilated retinal examination
Optical Coherence Tomography (OCT)
Fundus Autofluorescence (FAF)
Fluorescein Angiography (when required)
Visual field testing
Electroretinography (ERG)
Genetic testing to identify inherited mutations

These tests help distinguish CACD from conditions such as Stargardt disease, cone dystrophy, and age-related macular degeneration.

Treatment for Central Areolar Choroidal Dystrophy

Currently, there is no approved treatment that can stop or reverse CACD because it is an inherited retinal disease.

Management focuses on preserving remaining vision and improving quality of life.

Treatment may include:

Regular retinal monitoring
Low vision rehabilitation
Magnifying devices
Electronic visual aids
Protective sunglasses for light sensitivity
Genetic counseling for affected families

Patients should maintain regular follow-up with a retina specialist to monitor disease progression.

Can Stem Cell Therapy Help?

Stem cell therapy is being actively investigated as a potential regenerative treatment for inherited retinal disorders, including macular dystrophies. Researchers are studying whether stem cells may help replace or support damaged retinal cells in the future.

However, there is currently no universally approved stem cell treatment specifically proven to cure Central Areolar Choroidal Dystrophy. Patients considering regenerative therapies should seek evaluation from qualified ophthalmologists and discuss available clinical evidence before making treatment decisions.

Living with CACD

Although central vision gradually declines, many people continue to live independently by adopting visual rehabilitation strategies.

Helpful recommendations include:

Schedule routine retinal examinations.
Use prescribed low-vision devices.
Improve home lighting.
Wear UV-protective sunglasses outdoors.
Eat a balanced diet that supports overall eye health.
Seek genetic counseling if there is a family history.

Early diagnosis allows patients to receive appropriate support before significant vision loss occurs.

When Should You See an Eye Specialist?

Consult a retina specialist immediately if you notice:

Sudden or progressive central vision loss
Blurred vision that does not improve
Difficulty reading despite updated glasses
Distorted straight lines
Family history of inherited retinal diseases

Early evaluation helps establish the correct diagnosis and appropriate monitoring plan.

Frequently Asked Questions (FAQs)

1. Is Central Areolar Choroidal Dystrophy hereditary?

Yes. CACD is primarily an inherited retinal disorder and is most commonly associated with mutations in the PRPH2 gene.

2. At what age does CACD usually begin?

Symptoms commonly develop between the ages of 30 and 60 years, although onset may vary depending on the underlying genetic mutation.

3. Does CACD cause complete blindness?

CACD mainly affects central vision. Peripheral vision often remains preserved, so complete blindness is uncommon.

4. Can glasses cure CACD?

No. Glasses cannot stop disease progression, but low-vision aids may improve daily visual function.

5. Is genetic testing recommended?

Yes. Genetic testing can help confirm the diagnosis, identify the responsible mutation, and assist with family counseling.

6. Is stem cell therapy available for CACD?

Stem cell therapy is an active area of research, but there is currently no established, approved stem cell cure for CACD.

7. Can CACD be mistaken for macular degeneration?

Yes. Early CACD can resemble age-related macular degeneration, making specialized retinal imaging and genetic evaluation important for accurate diagnosis.

Conclusion

Central Areolar Choroidal Dystrophy is a rare inherited macular disease that progressively affects central vision. Although there is Stem cell treatment for CACD in India, definitive cure today, advances in retinal imaging, genetic testing, low-vision rehabilitation, and ongoing regenerative medicine research are improving diagnosis and long-term patient care. Individuals experiencing unexplained central vision changes should seek prompt evaluation from an experienced retina specialist for early diagnosis and appropriate management.